The ‘glymphatic’ system, which has recently been identified using MRI, is a brain-wide pathway for removal of waste solutes. This system is implicated in Alzheimer’s disease (AD), due to discovery that both amyloid-β and tau, accumulations that define AD, are cleared from the brain via this pathway. Using contrast-enhanced MRI, we demonstrate that glymphatic function is dependent upon aquaporin-4, a water channel located on astrocytic endfeet surrounding blood vessels in the brain. Herein, using a novel pharmacological approach, we show that aquaporin-4 represents a suitable drug target for manipulation of glymphatic function in the brain, and in treatment of AD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords